| P50 | author | Matthew J Pace | Q82080707 |
| P2093 | author name string | Angela Mexas | |
| | Avinash Bhandoola | |
| | Una O'Doherty | |
| | Erin Graf | |
| | Jianqing J. Yu | |
| | Megan K. Liszewski | |
| | Luis M. Agosto | |
| P2860 | cites work | Depletion of latent HIV-1 infection in vivo: a proof-of-concept study | Q28111910 |
| | Macrophage are the principal reservoir and sustain high virus loads in rhesus macaques after the depletion of CD4+ T cells by a highly pathogenic simian immunodeficiency virus/HIV type 1 chimera (SHIV): Implications for HIV-1 infections of humans | Q28345408 |
| | Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein | Q28472613 |
| | Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy | Q29615992 |
| | HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation | Q29619611 |
| | Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection | Q29619738 |
| | In vivo evidence for instability of episomal human immunodeficiency virus type 1 cDNA. | Q33724206 |
| | Both memory and CD45RA+/CD62L+ naive CD4(+) T cells are infected in human immunodeficiency virus type 1-infected individuals | Q33816825 |
| | Quantitative infectivity assay for HIV-1 and-2. | Q44819439 |
| | Efficient lentiviral vector-mediated control of HIV-1 replication in CD4 lymphocytes from diverse HIV+ infected patients grouped according to CD4 count and viral load | Q44933959 |
| | Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals | Q45428919 |
| | Evolution of total and integrated HIV-1 DNA and change in DNA sequences in patients with sustained plasma virus suppression | Q45730077 |
| | Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes | Q45733837 |
| | In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). | Q45836762 |
| | Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection | Q45854138 |
| | Establishment of drug-resistant HIV-1 in latent reservoirs. | Q46065447 |
| | Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro | Q46066602 |
| | Safe two-plasmid production for the first clinical lentivirus vector that achieves >99% transduction in primary cells using a one-step protocol. | Q51620649 |
| | HIV-1 can persist in aged memory CD4+ T lymphocytes with minimal signs of evolution after 8.3 years of effective highly active antiretroviral therapy. | Q51824151 |
| | The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. | Q52030166 |
| | In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. | Q52050894 |
| | Loss of neoplastic properties in vitro. II. Observations on KB sublines | Q72580566 |
| | Evidence that low-level viremias during effective highly active antiretroviral therapy result from two processes: expression of archival virus and replication of virus | Q33908838 |
| | HIV-1 replication is controlled at the level of T cell activation and proviral integration | Q33919765 |
| | Human immunodeficiency virus type 1 can establish latent infection in resting CD4+ T cells in the absence of activating stimuli | Q34124009 |
| | Genotypic analysis of HIV-1 drug resistance at the limit of detection: virus production without evolution in treated adults with undetectable HIV loads | Q34312257 |
| | Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy. | Q34357238 |
| | Infection of monocyte/macrophages by human T lymphotropic virus type III. | Q34579117 |
| | HIV-1 pathogenesis | Q35166833 |
| | Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication | Q35838477 |
| | Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. | Q35839212 |
| | Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection | Q36225040 |
| | Experimental approaches to the study of HIV-1 latency | Q36708954 |
| | Integration is not necessary for expression of human immunodeficiency virus type 1 protein products | Q36806287 |
| | Continued production of drug-sensitive human immunodeficiency virus type 1 in children on combination antiretroviral therapy who have undetectable viral loads | Q36943833 |
| | A more precise HIV integration assay designed to detect small differences finds lower levels of integrated DNA in HAART treated patients | Q37030314 |
| | Biphasic decay kinetics suggest progressive slowing in turnover of latently HIV-1 infected cells during antiretroviral therapy | Q37072991 |
| | Viral reservoirs, residual viremia, and the potential of highly active antiretroviral therapy to eradicate HIV infection. | Q37207653 |
| | Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors | Q37257484 |
| | Detecting HIV-1 integration by repetitive-sampling Alu-gag PCR. | Q37386023 |
| | Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs | Q37615893 |
| | Molecular control of HIV-1 postintegration latency: implications for the development of new therapeutic strategies | Q37644561 |
| | HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy | Q38460522 |
| | The CXCR4-tropic human immunodeficiency virus envelope promotes more-efficient gene delivery to resting CD4+ T cells than the vesicular stomatitis virus glycoprotein G envelope | Q38862435 |
| | Human immunodeficiency virus type 1 spinoculation enhances infection through virus binding | Q39539552 |
| | Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication | Q39683177 |
| | Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles | Q39683262 |
| | A sensitive, quantitative assay for human immunodeficiency virus type 1 integration | Q39685335 |
| | Identification and characterization of a temperature-sensitive mutant of human immunodeficiency virus type 1 by alanine scanning mutagenesis of the integrase gene | Q39868558 |
| | Analysis of early human immunodeficiency virus type 1 DNA synthesis by use of a new sensitive assay for quantifying integrated provirus | Q39996408 |
| | Integration is essential for efficient gene expression of human immunodeficiency virus type 1. | Q40044176 |
| | HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration. | Q40106981 |
| | Repetitive sequences in eukaryotic DNA and their expression | Q40338293 |
| | Cell cycle arrest in G2/M promotes early steps of infection by human immunodeficiency virus | Q40435980 |
| | A quantitative assay for HIV DNA integration in vivo | Q40809319 |
| | Analysis of human immunodeficiency virus type 1 integrase mutants | Q41321604 |
| | Alu sequences | Q41658951 |
| | Intensification of antiretroviral therapy accelerates the decay of the HIV-1 latent reservoir and decreases, but does not eliminate, ongoing virus replication | Q42616666 |
| | HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects. | Q43130032 |
| | Quantification of integrated and total HIV-1 DNA after long-term highly active antiretroviral therapy in HIV-1-infected patients | Q44022665 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | highly active antiretroviral therapy | Q3536652 |
| | virus latency | Q4115619 |
| | virus integration | Q70684004 |
| P304 | page(s) | 46-53 | |
| P577 | publication date | 2011-01-01 | |
| | 2011-01-05 | |
| P1433 | published in | Virology | Q7934867 |
| P1476 | title | Patients on HAART often have an excess of unintegrated HIV DNA: implications for monitoring reservoirs | |
| | Patients on HAART often have an excess of unintegrated HIV DNA: Implications for monitoring reservoirs | |
| P478 | volume | 409 | |